NIH-funded research R01 grant

Assessing personalized risks in Neurofibromatosis Type 1

Official title: Personalized risk assessment in Neurofibromatosis Type 1

Funded at Washington University · NIH-11055330 · Data updated 2026-11-12

This study is looking at Neurofibromatosis Type 1 (NF1) to create smart tools that help doctors understand and predict health issues related to NF1, so they can provide better care and support for patients like you.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$554,337
NIH project number5R01NS131112-03
Project IDNIH-11055330 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Neurofibromatosis Type 1, regardless of age, who are seeking better management of their condition.

Less likely to help

Patients without a diagnosis of Neurofibromatosis Type 1 or those with other unrelated conditions may not benefit from this research.

What this research studies

This research focuses on Neurofibromatosis Type 1 (NF1), a genetic disorder that can lead to various tumors and health complications. The study aims to develop artificial intelligence-based tools to better understand and predict the clinical features and risks associated with NF1. By analyzing individual patient data, the research seeks to create more accurate risk assessments and improve management strategies for those affected by NF1. This approach aims to shift from reactive to proactive care, enhancing the quality of life for patients.

Why it matters

Potential benefit: If successful, this research could lead to more personalized and effective management strategies for individuals with Neurofibromatosis Type 1.

How similar studies have gone: Previous research has shown promise in using artificial intelligence for clinical decision-making in other genetic disorders, suggesting potential success for this novel approach in NF1.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Gupta, Aditi — Washington University
  • Study coordinator: Gupta, Aditi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.